In the last few weeks, I've become more and more critical about the British music company EMI Group, especially with the coming release of Coldplay's fourth album Viva la Vida or Death and All His Friends. Numerous reports and rumors are circulating that the company is betting all of its yearly profits on the album's success, and this only fuels my fears about the success that the album would enjoy. It was never in doubt that the album would be huge, but with the band hoping to shake the image of a band that earns more profits for label management, the rumors worked against that.
In any case, I finally bought the album this morning from Best Buy Co., Inc. (NYSE: BBY) and was slightly surprised to see that the retail chain was carrying a very limited number of vinyl copies. Naturally, and possibly without thinking of my Apple Inc. (NASDAQ: AAPL) iPod, I splurged for this version of the album. Regardless, when I finally opened the shrinkwrap I found another surprise -- a CD copy packaged with the vinyl. Clearly, EMI and American branch Capitol Records are aware that a vinyl copy hardly transfers to an iPod easily.
The label may not like the fact that I will burn that CD copy to my iPod because of lingering fears that somehow that will result in illegal sharing, but it does say something possibly revealing about EMI. Since Guy Hands and private equity firm Terra Firma bought out the music company last September, the company has taken steps that some view as not music company practices, and lost many big artists in the mean time. But if a consumer can purchase one copy of an album from the music giant and receive two, then the company might not be in such trouble.
That is the very dynamic that the music industry needed to show: that it cared about the consumer. Digital growth in the past year has indicated that it did, and while a vinyl and CD copy might seem against that trend, it shows that the industry knows where consumers are listening to music the most: through portable devices.
Last updated: February 10, 2012: 02:06 AM
Hot Stocks
DailyFinance Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
Benzinga Headlines
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
TheFlyOnTheWall.com Headlines
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

